Potential of an LRG1-Targeting Degrader in Combating Aggressive Triple-Negative Breast Cancer
Abstract Triple-negative breast cancer (TNBC) remains clinically challenging due to its aggressive phenotype and the scarcity of druggable targets. Leucine-rich alpha-2-glycoprotein 1 (LRG1) is a critical driver of TNBC progression, yet its has precluded the development of conventional occupancy-driven inhibitors. In this study, we employed an event-driven proteolysis-targeting chimera (PROTAC) strategy to target this “undruggable” LRG1 for degradation. Leveraging our previously developed ETTAC-2─a peptide-based PROTAC with established efficacy in ocular neovascularization and renal fibrosis models─we demonstrate that this degrader induces effective LRG1 degradation via the ubiquitin-proteasome system in a dose- and time-dependent manner in 4T1 TNBC cells. Mechanistically, ETTAC-2-mediated degradation of LRG1 suppressed the p-AKT and HIF-1α signaling axes, impairing cell proliferation in vitro and orchestrating a robust antitumor response in vivo. Systemic administration of ETTAC-2 significantly attenuated mammary tumor growth and impeded the aggressive phenotype by reversing the epithelial-mesenchymal transition (EMT) program through sustained inhibition of HIF-1α signaling. By effectively reversing EMT markers and curtailing the malignant progression of TNBC without observable systemic toxicity, our findings validate LRG1 as a viable therapeutic target and establish ETTAC-2 as a pioneering lead compound that bypasses structural limitations to treat recalcitrant breast cancers.
Authors
- Shiyu Song (ORCID: https://orcid.org/0009-0008-5692-3070)
- Yingqiu Qi (ORCID: https://orcid.org/0009-0002-7271-4355)
- Huan Min (ORCID: https://orcid.org/0000-0003-1220-3377)
- Yao Li (ORCID: https://orcid.org/0000-0001-6605-4069)
- Xiaoming Zhu
- Furong Zhu
- Yating Wang
- Yu Li
- Yongzheng Li
Institutions
- Macau University of Science and Technology (MO)
- Zhejiang Sci-Tech University (CN)
- Zhengzhou University (CN)
Publication Details
- Journal
- ACS Omega
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1021/acsomega.6c07595
- Primary Topic
- Protein Degradation and Inhibitors
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Henan Provincial Science and Technology Research Project